INVITRO INTERNATIONAL ENGAGES ASKEW KABALA AND COMPANY, INC. TO FURTHER ADVANCE ITS CORPORATE GROWTH PLAN
September 3, 2024
INVITRO INTERNATIONAL SEES REAL POSITIVES IN START TO FY ‘24
February 14, 2024
IVRO ANNOUNCES FISCAL Q #3 2023 RESULTS WHILE CONTINUING M&A STRATEGY TO MAKE NON-ANIMAL TESTING FAMOUS
August 9, 2023
IVRO ADVANCES CORE STRATEGY TO MAKE NON-ANIMAL TESTING FAMOUS, ANNOUNCES FISCAL Q2 2023 RESULTS
May 11, 2023
IVRO ADVANCES CORE STRATEGY TO MAKE NON-ANIMAL TESTING FAMOUS, ANNOUNCES FISCAL Q1 2023 RESULTS
February 8, 2023
IVRO CONTINUES TO HELP MAKE NON-ANIMAL TESTING FAMOUS, RELEASES FISCAL 2022 RESULTS
December 8, 2022
IVRO EXPLORES OPPORTUNITY FOR GROWTH
November 16, 2022
IVRO CONTINUES TO HELP MAKE NON-ANIMAL TESTING FAMOUS, RELEASES FISCAL Q3 2022 RESULTS
August 10, 2022
IVRO WITH A MISSION TO HELP MAKE NON-ANIMAL TESTING FAMOUS, RELEASES FISCAL Q2 2022 RESULTS
April 26, 2022
IVRO WITH A MISSION TO HELP MAKE NON ANIMAL TESTING FAMOUS, RELEASES FISCAL 2021 RESULTS
December 8, 2021
IVRO’S MISSION TO HELP MAKE NON ANIMAL TESTING FAMOUS NOW SEARCHES FOR STRATEGIC PARTNERS
September 1, 2021
IVRO PURSUES MISSION TO “HELP MAKE NON ANIMAL TESTING FAMOUS”; RELEASES FY Q3 AND YTD 2021 RESULTS
August 4, 2021
IVRO CONTINUES ITS MISSION TO “HELP MAKE NON ANIMAL TESTING FAMOUS”; RELEASES FY Q2 AND YTD 2021 RESULTS
May 11, 2021
INVITRO INTERNATIONAL, A PIONEER IN NON-ANIMAL TESTING ALTERNATIVES FOR OCULAR AND DERMAL TOXICITY RELEASES FY Q1 2021 RESULTS
February 10, 2021
INVITRO INTERNATIONAL, A PIONEER IN NON-ANIMAL TESTING ALTERNATIVES FOR OCULAR AND DERMAL TOXICITY RELEASES FY 2020 RESULTS
December 7, 2020
INVITRO INTERNATIONAL REPORTS FY 2016 A YEAR OF SOLID PROGRESS WITH AN UNUSUAL LOOK
January 31, 2017
INVITRO INTERNATIONAL REPORTS OUTSTANDING FY 2015 FINANCIAL RESULTS, AND CORE TECHNOLOGY REGULATORY PROGRESS
February 2, 2016
INVITRO INTERNATIONAL REPORTS POSITIVE FINANCIAL IMPACT OF RELOCATION; FY 2014 FINANCIAL RESULTS, AND 1ST QUARTER FY 201 SALES JUMP
February 3, 2015
INVITRO INTERNATIONAL REPORTS IMPORTANT FY 2013 & Q1 FY 2014 REGULATORY PROGRESS, SMALL NET PROFITS
January 22, 2014
INVITRO INTERNATIONAL REPORTS POSITIVE 1ST QUARTER FY 2013 FOLLOWING FY 2012 DECLINE
January 23, 2013
INVITRO INTERNATIONAL REPORTS 1ST QUARTER FY 2010 SALES JUMP 24% FOLLOWING FY 2010/2009 DECLINE
January 19, 2011
INVITRO INTERNATIONAL FY 2009 SALES REACH HIGHEST LEVEL IN 12 YEARS
January 13, 2010
INVITRO INTERNATIONAL RECORDS HEALTHY FY ’08 SALES & PROFIT RESULTS
January 13, 2009
INVITRO INTERNATIONAL POSTS EARLY FY ’07 SALES & PROFIT GAINS FOLLOWING MODEST FY ’06 RESULTS
March, 2007
INVITRO INTERNATIONAL SALES ADVANCE IN ITS PROFITABLE FY 2003; NEW GLOBAL PARTNERSHIP BEGINS
November, 2003
INVITRO INTERNATIONAL FINISHES FY 2001 WITH SMALL PROFIT DESPITE ANNUAL SALES DECLINE
January, 2002 — Sales jump in First Quarter 2002
INVITRO INTERNATIONAL’S 1st HALF FY 2001 PRODUCES NET PROFIT VS. PRIOR YEAR LOSS;
May, 2001 — Website Database Sales To Start Soon
INVITRO INTERNATIONAL’S Y2K RESULTS
January, 2001 — Feature added global government support
INVITRO INTERNATIONAL REPORTS 1ST HALF 2000 OPERATING INCOME ON INCREASED SALES
May, 2000 — U.S. Government Agency Approvals expected to brighten future
INVITRO INTERNATIONAL POSTS 4TH CONSECUTIVE PROFITABLE QUARTER
Jan, 2000 — Full year ’99 sales up 16%, net profit at 9.4%
INVITRO INTERNATIONAL POSTS 3RD CONSECUTIVE PROFITABLE QUARTER
Aug, 1999 — Company also receives Corrositex endorsement from government sponsored science panel
INVITRO INTERNATIONAL REPORTS SECOND QUARTER PROFITS
May, 1999 — Sales & Cash Increase 6th Consecutive Quarter
INVITRO INTERNATIONAL REPORTS FIRST QUARTER PROFITABLE
February, 1999 — Sales & Cash Increase 5th Consecutive Quarter
INVITRO INTERNATIONAL REPORTS FOURTH QUARTER PROFITABLE, BEFORE INVENTORY WRITE OFF
January, 1999 — Sales & Cash Increase 4th Consecutive Quarter
INVITRO SALES, CASH INCREASE AGAIN; MERGER PLANS UPDATE
July, 1998 — Revenues and cash increase third consecutive quarter
INVESTOR RELATIONS FIRM SIGNED
June, 1998 — Makenna Delaney & Sullivan, Inc. to assist the firm
FINANCIAL HIGHLIGHTS
May, 1998 — Revenue Increases 2% Over Previous Quarter
PRESIDENT’S LETTER
January, 1998 — Lowest Quarterly Loss Since Becoming A Public Company
FINANCIAL HIGHLIGHTS
January, 1998 — First Quarter ended December 31, 1997
FINANCIAL HIGHLIGHTS
November, 1997 — Fiscal Year Ended September 30, 1997
INVITRO INTERNATIONAL REPORTS THIRD QUARTER RESULTS
August 15, 1997 — Company Announces Lowest Quarterly Loss and Expands Merger Options
INVITRO INTERNATIONAL REPORTS SECOND QUARTER RESULTS
May 15, 1997 — Company Signs Merger Letter Of Intent With Miragen
INVITRO INTERNATIONAL SIGNS MERGER LETTER OF INTENT
March 3, 1997 — IVI announces it has signed a letter of intent to merge with Shenyang International Inc.
INVITRO INTERNATIONAL REPORTS FIRST QUARTER RESULTS
INVITRO INTERNATIONAL REPORTS YEAR-END RESULTS
December 18, 1996 — Net Annual Loss Lowest In Company’s Public History
InVitro International
330 E. Orangethorpe Ave., Suite D
Placentia, CA 92870
800-2-INVITRO (800-246-8487)
949-851-8356 (International callers)
949- 851-4985 Fax